The UK has agreed a supply deal for 250,00 courses of Paxlovid, without revealing the purchase price, along with 480,000 doses of molnupiravir. Pfizer said it is already in advanced purchase ...

Paxlovid had 89% efficacy in preventing hospitalisation ... Its data looks much stronger than that for molnupiravir, which saw a top-line efficacy of a 48% reduction in hospitalisation and death ...